Bruce A. Larson, PhD

Research Professor, Global Health
Bruce Larson
(617) 414-1457blarson@bu.edu
Crosstown Center – 378
View full profile at BUMC

Biography

Dr. Larson is an applied economist with the Department of Global Health and the Center for Global Health and Development (CGHD). Dr. Larson has conducted research activities in about 25 countries over the past 28 years, mainly in Africa, the former Soviet Union and the US. Before joining Boston University, Larson was an Associate Professor in the Department of Agricultural and Resource Economics at the University of Connecticut, a Research Associate with the Harvard Institute for International Development, a Research Fellow with Winrock International, and an Agricultural Economist with the U.S. Department of Agriculture. As part of these activities, he was based in Tallinn, Riga, and Moscow during 1994-1997 and Nairobi during 2005-2006. Since joining Boston University, his research has focused on economic evaluations of public health programs and interventions in clinical and community settings with experimental and quasi-experimental designs. Most of this evaluation work has been based on primary data collected in collaboration with colleagues and institutions in the country of focus (e.g., the Kenya Medical Research Institute/ Walter Reed Project, the Health Economics and Epidemiology Office of the University of Witwatersrand, and the Zambia Centre for Applied Health Research and Development). His evaluation research has addressed a range of topics, such as the impacts of HIV treatment on labor productivity, costs and usefulness of point-of-care technologies (CD4 tests, rapid syphilis tests, rapid malaria tests), costs of HIV care and treatment, and improving delivery of prevention of mother-to-child transmission). Note: The publications list below does not include publications outside of public health (e.g. agriculture, environment, development, international trade). See, for example, EconLit for these other publications.

Education

  • University of Wisconsin Madison, PhD
  • University of Wisconsin Madison, MA
  • University of Wisconsin Madison, BA

Classes Taught

  • SPHGH762
  • SPHGH770

Publications

  • Published on 10/26/2017

    Meyer-Rath G, van Rensburg C, Larson B, Jamieson L, Rosen S. Revealed willingness-to-pay versus standard cost-effectiveness thresholds: Evidence from the South African HIV Investment Case. PLoS One. 2017; 12(10):e0186496. PMID: 29073167.

    Read at: PubMed
  • Published on 5/28/2017

    Rosen S, Fox MP, Larson BA, Brennan AT, Maskew M, Tsikhutsu I, Bii M, Ehrenkranz PD, Venter WF. Simplified clinical algorithm for identifying patients eligible for immediate initiation of antiretroviral therapy for HIV (SLATE): protocol for a randomised evaluation. BMJ Open. 2017 May 28; 7(5):e016340. PMID: 28554939.

    Read at: PubMed
  • Published on 1/31/2017

    Chiu C, Johnson LF, Jamieson L, Larson BA, Meyer-Rath G. Designing an optimal HIV programme for South Africa: Does the optimal package change when diminishing returns are considered? BMC Public Health. 2017 Jan 31; 17(1):143. PMID: 28143525.

    Read at: PubMed
  • Published on 8/11/2016

    Larson BA, Ngoma T, Silumbe K, Rutagwera MR, Hamainza B, Winters AM, Miller JM, Scott CA. A framework for evaluating the costs of malaria elimination interventions: an application to reactive case detection in Southern Province of Zambia, 2014. Malar J. 2016 Aug 11; 15(1):408. PMID: 27515533.

    Read at: PubMed
  • Published on 8/9/2016

    Rosen S, Fox MP, Larson BA, Sow PS, Ehrenkranz PD, Venter F, Manabe YC, Kaplan J. Accelerating the Uptake and Timing of Antiretroviral Therapy Initiation in Sub-Saharan Africa: An Operations Research Agenda. PLoS Med. 2016 Aug; 13(8):e1002106. PMID: 27505444.

    Read at: PubMed
  • Published on 7/8/2016

    Larson BA, Rockers PC, Bonawitz R, Sriruttan C, Glencross DK, Cassim N, Coetzee LM, Greene GS, Chiller TM, Vallabhaneni S, Long L, van Rensburg C, Govender NP. Screening HIV-Infected Patients with Low CD4 Counts for Cryptococcal Antigenemia prior to Initiation of Antiretroviral Therapy: Cost Effectiveness of Alternative Screening Strategies in South Africa. PLoS One. 2016; 11(7):e0158986. PMID: 27390864.

    Read at: PubMed
  • Published on 4/15/2015

    Halim N, Spielman K, Larson B. The economic consequences of selected maternal and early childhood nutrition interventions in low- and middle-income countries: a review of the literature, 2000-2013. BMC Womens Health. 2015; 15:33. PMID: 25887257.

    Read at: PubMed
  • Published on 3/16/2015

    Larson B, Tindikahwa A, Mwidu G, Kibuuka H, Magala F. How much does it cost to improve access to voluntary medical male circumcision among high-risk, low-income communities in Uganda? PLoS One. 2015; 10(3):e0119484. PMID: 25774677.

    Read at: PubMed
  • Published on 2/6/2015

    Schnippel K, Mongwenyana C, Long LC, Larson BA. Delays, interruptions, and losses from prevention of mother-to-child transmission of HIV services during antenatal care in Johannesburg, South Africa: a cohort analysis. BMC Infect Dis. 2015; 15:46. PMID: 25656597.

    Read at: PubMed
  • Published on 12/15/2014

    Marseille E, Larson B, Kazi DS, Kahn JG, Rosen S. Thresholds for the cost-effectiveness of interventions: alternative approaches. Bull World Health Organ. 2015 Feb 01; 93(2):118-24. PMID: 25883405.

    Read at: PubMed

View 31 more publications:View full profile at BUMC

News & In the Media